Colony‐stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia

BACKGROUND: Acute myelogenous leukemia (AML) is a fatal bone marrow cancer. Colony‐stimulating factors (CSFs) are frequently administered during and after chemotherapy to reduce complications. However, their safety with regard to disease‐related outcomes and survival in AML is unclear. Therefore, we...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Cochrane Database Syst Rev
Główni autorzy: Gurion, Ronit, Belnik‐Plitman, Yulia, Gafter‐Gvili, Anat, Paul, Mical, Vidal, Liat, Ben‐Bassat, Isaac, Shpilberg, Ofer, Raanani, Pia
Format: Artigo
Język:Inglês
Wydane: John Wiley & Sons, Ltd 2012
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7390444/
https://ncbi.nlm.nih.gov/pubmed/22696376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008238.pub3
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy